期刊文献+

DBC2在胃癌中的甲基化 被引量:1

Study on Methylation of DBC2 in Gastric Cancer
下载PDF
导出
摘要 目的检测DBC2在胃癌组织中的表达水平及其基因启动子区的甲基化状态,从而探讨二者的相关性。方法选取92例胃癌组织及其相应的癌旁组织为研究对象,通过RT-PCR方法检测DBC2 m RNA表达水平,并利用MS-PCR方法检测DBC2启动子区的甲基化状态,同时分析胃癌组织中DBC2启动子区甲基化水平与临床病理因素的相关性。结果与癌旁组织相比,胃癌组织中DBC2的表达水平降低,同时伴随其启动子区高甲基化。其甲基化水平与肿瘤浸润深度、分化程度及TNM分期密切相关(P<0.05),随着肿瘤浸润深度的增加、分化程度的降低以及TNM分期的提高,胃癌组织中DBC2启动子区具有更明显的甲基化水平。结论胃癌中DBC2启动子区高甲基化可能是导致其表达水平降低的一个重要原因。 Objective To detect the expression of DBC2 and the methylation status of its gene promoter region in gastric cancer, so as to analyze their correlation. Methods Gastric cancer tissues and adjacent normal tissues were collected from 92 cases as research subjects. The DBC2 mRNA expression and the methylation status of DBC2 gene promoter region in gastric cancer were detected by using RT-PCR and MS-PCR respectively. In addition, the correlation of DBC2 gene methylation status with elinicopathological parameters was analyzed. Results In comparison with adjacent normal tissues, gastric cancer tissues displayed a low expression level of DBC2 mRNA and a high methylation level of gene promoter region. Besides, the methylation level was significantly correlated with tumor invasion depth, differentiation and TNM staging ( P 〈 0.05 ). With deep invasion, poor differentiation or higher TNM staging, methylation level of gene promoter region was more significant in gastric cancer tissues. Conclusion High methylation of DBC2 gene promoter region may be a significant contributing factor leading to low DBC2 expression.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2015年第2期132-135,共4页 Journal of China Medical University
基金 辽宁省自然科学基金(201102108) 沈阳市科技计划项目(F13-220-9-52)
关键词 胃癌 甲基化 DBC2 gastric cancer methylation DBC2
  • 相关文献

参考文献7

  • 1Ohadi M, Totonchi M, Maguire P, et al. Mutation analysis of the DBC2 gene in sporadic and familial breast cancer[J]. Acta Oncol, 2007,46(6) : 770-772.
  • 2Tang W, Wang C, Fu F, et al. RhoBTB2 gene in breast cancer is si- lenced by promoter methylation [J] Int J Mol Med, 2014, 33 (3) : 722-728.
  • 3Mao H, Zhang L, Yang Y, et al. RhoBTB2 (DBC2) functions as tu- mor suppressor via inhibiting proliferation, preventing colony forma- tion and inducing apoptosis in breast cancer cells [J ]. Gene, 2011, 486(1-2) : 74-80.
  • 4Shen J, Wet J, Wang H, et al. SULF2 methylation is associated with in vitro cisplatin sensitivity and clinical efficacy for gastric cancer patients treated with a modified FOLFOX regimen [J]. PloS One, 2013,8 (10) : e75564.
  • 5Zhao J, Liang Q, Cheung KF, et al. Genome-wide identification of Epstein-Barr virus- driven promoter methylation profiles of human genes in gastric cancer cells[J]. Cancer,2013,119(2) :304-312.
  • 6Shi Y, Chen JY, Yang J, et al. DBC2 gene is silenced by promoter methylation in bladder cancer [J]. Urol Oncol, 2008, 26 (5) : 465 -469.
  • 7Knowles MA, Aveyard JS, Taylor CF, et al. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer [ J ]. Cancer Lett, 2005,225 ( 1 ) : 121-130.

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部